
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension
Yicheng Yang, Qixian Zeng, Jianing Gao, et al.
European Heart Journal Open (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 17
Yicheng Yang, Qixian Zeng, Jianing Gao, et al.
European Heart Journal Open (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 17
Showing 17 citing articles:
Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota
Yicheng Yang, Hanwen Zhang, Yaoyao Wang, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 9
Yicheng Yang, Hanwen Zhang, Yaoyao Wang, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 9
Gut microbiota dependant trimethylamine N-oxide and hypertension
Katongo Hope Mutengo, Sepiso K. Masenga, Aggrey Mweemba, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 23
Katongo Hope Mutengo, Sepiso K. Masenga, Aggrey Mweemba, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 23
Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives
Yuan Lin, Ying Li, Moutong Chen, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 8
Yuan Lin, Ying Li, Moutong Chen, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 8
Targeting Lung–Gut Axis for Regulating Pollution Particle–Mediated Inflammation and Metabolic Disorders
Tzu-Yu Cheng, Chih‐Cheng Chang, Ching-Shan Luo, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 901-901
Open Access | Times Cited: 16
Tzu-Yu Cheng, Chih‐Cheng Chang, Ching-Shan Luo, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 901-901
Open Access | Times Cited: 16
Pleiotropic activities of succinate: The interplay between gut microbiota and cardiovascular diseases
Jing Xu, Yicheng Yang, Xin Li, et al.
iMeta (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 12
Jing Xu, Yicheng Yang, Xin Li, et al.
iMeta (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 12
Trimethylamine N-Oxide (TMAO) Acts as Inhibitor of Endothelial Nitric Oxide Synthase (eNOS) and Hampers NO Production and Acetylcholine-Mediated Vasorelaxation in Rat Aortas
Alma Martelli, Francesca Abate, Michele Roggia, et al.
Antioxidants (2025) Vol. 14, Iss. 5, pp. 517-517
Open Access
Alma Martelli, Francesca Abate, Michele Roggia, et al.
Antioxidants (2025) Vol. 14, Iss. 5, pp. 517-517
Open Access
The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
Albert Stec, Magdalena Maciejewska, Karolina Paralusz-Stec, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1895-1904
Open Access | Times Cited: 9
Albert Stec, Magdalena Maciejewska, Karolina Paralusz-Stec, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1895-1904
Open Access | Times Cited: 9
Multi-metabolomics and intestine microbiome analysis: YZC extract ameliorates septic-ALI by modulating intestine microbiota to reduce TMAO/NLRP3 signaling
Xia Cao, Mantong Zhao, Xiao Wang, et al.
Phytomedicine (2024) Vol. 130, pp. 155345-155345
Closed Access | Times Cited: 3
Xia Cao, Mantong Zhao, Xiao Wang, et al.
Phytomedicine (2024) Vol. 130, pp. 155345-155345
Closed Access | Times Cited: 3
Causal impact of gut microbiota and associated metabolites on pulmonary arterial hypertension: a bidirectional Mendelian randomization study
Xin Li, Jiang-Shan Tan, Jing Xu, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Xin Li, Jiang-Shan Tan, Jing Xu, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Low-Molecular-Weight Compounds Produced by the Intestinal Microbiota and Cardiovascular Disease
Lorena Cuervo, Patrick L. McAlpine, Carlos Olano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10397-10397
Open Access | Times Cited: 2
Lorena Cuervo, Patrick L. McAlpine, Carlos Olano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10397-10397
Open Access | Times Cited: 2
The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension – a cohort study
Yicheng Yang, Xin Li, Peizhi Wang, et al.
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access | Times Cited: 2
Yicheng Yang, Xin Li, Peizhi Wang, et al.
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access | Times Cited: 2
3,3-Dimethyl-1-Butanol and its Metabolite 3,3-Dimethylbutyrate Ameliorate Collagen-induced Arthritis Independent of Choline Trimethylamine Lyase Activity
Sabrina Fechtner, Brendan Allen, Meagan E. Chriswell, et al.
Inflammation (2024)
Open Access | Times Cited: 1
Sabrina Fechtner, Brendan Allen, Meagan E. Chriswell, et al.
Inflammation (2024)
Open Access | Times Cited: 1
Circulating choline levels are associated with prognoses in patients with pulmonary hypertension: a cohort study
Yicheng Yang, Beilan Yang, Bingyang Liu, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Yicheng Yang, Beilan Yang, Bingyang Liu, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension
Jingjing Zhou, Furong Li, Yicheng Yang
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Jingjing Zhou, Furong Li, Yicheng Yang
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Gut–Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension
Konrad Suswał, Michał Tomaszewski, Aleksandra Romaniuk-Drapała, et al.
Journal of Personalized Medicine (2023) Vol. 14, Iss. 1, pp. 8-8
Open Access | Times Cited: 2
Konrad Suswał, Michał Tomaszewski, Aleksandra Romaniuk-Drapała, et al.
Journal of Personalized Medicine (2023) Vol. 14, Iss. 1, pp. 8-8
Open Access | Times Cited: 2
Gut Microbiome and Pulmonary Arterial Hypertension – A Novel and Evolving Paradigm
Thenappan Thenappan, E. K. Weir
Physiological Research (2024), pp. S477-S485
Open Access
Thenappan Thenappan, E. K. Weir
Physiological Research (2024), pp. S477-S485
Open Access
3,3-dimethyl-1-butanol and its metabolite 3,3-dimethylbutyrate ameliorate collagen-induced arthritis independent of choline trimethylamine lyase activity
Sabrina Fechtner, Brendan Allen, Meagan E. Chriswell, et al.
Research Square (Research Square) (2023)
Open Access
Sabrina Fechtner, Brendan Allen, Meagan E. Chriswell, et al.
Research Square (Research Square) (2023)
Open Access